Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 13, 2022 09:00 ET | Source: Nacuity Pharmaceuticals, Inc.

Nacuity Pharmaceuticals and Arctic Therapeutics Enter Licensing Agreement and Strategic Partnership to Develop NPI-001

FORT WORTH, Texas and REYKJAVIK, Iceland, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa,...
June 15, 2022 07:30 ET | Source: Nacuity Pharmaceuticals, Inc.

Nacuity Pharmaceuticals Announces $16.5 Million Series B Financing Led by Foundation Fighting Blindness & RD Fund

FORT WORTH, Texas, June 15, 2022 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other...
August 24, 2021 07:30 ET | Source: Nacuity Pharmaceuticals, Inc.

Nacuity Pharmaceuticals Appoints Robert R. Ruffolo, Ph.D., to Board of Directors

FORT WORTH, Texas, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, a clinical stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts, and other ocular...